Blood test guides fight against stubborn lymphoma
NCT ID NCT07021989
Summary
This study is testing a combination of four drugs (pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin) for adults whose classic Hodgkin lymphoma has returned or not responded to initial treatment. It aims to see if this treatment can achieve a deep remission, measured by both imaging scans and a sensitive blood test that looks for tiny amounts of leftover cancer DNA. The blood test results will help decide if patients need additional, less intensive treatment to try to keep the cancer away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis
Davis, California, 95616, United States
-
University of California Irvine
Irvine, California, 92617, United States
-
University of California San Francisco-Fresno
Fresno, California, 93701, United States
-
University of California, San Diego
La Jolla, California, 92093, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
Contact
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unversity of California, Los Angeles
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.